Frontotemporal lobar degeneration

M Grossman, WW Seeley, AL Boxer, AE Hillis… - Nature Reviews …, 2023 - nature.com
Frontotemporal lobar degeneration (FTLD) is one of the most common causes of early-onset
dementia and presents with early social–emotional–behavioural and/or language changes …

[HTML][HTML] MAPT mutations, tauopathy, and mechanisms of neurodegeneration

KH Strang, TE Golde, BI Giasson - Laboratory investigation, 2019 - Elsevier
In multiple neurodegenerative diseases, including Alzheimer's disease (AD), a prominent
pathological feature is the aberrant aggregation and inclusion formation of the microtubule …

[HTML][HTML] Structure-based classification of tauopathies

Y Shi, W Zhang, Y Yang, AG Murzin, B Falcon… - Nature, 2021 - nature.com
The ordered assembly of tau protein into filaments characterizes several neurodegenerative
diseases, which are called tauopathies. It was previously reported that, by cryo-electron …

[HTML][HTML] ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids

KR Bowles, MC Silva, K Whitney, T Bertucci, JE Berlind… - Cell, 2021 - cell.com
Frontotemporal dementia (FTD) because of MAPT mutation causes pathological
accumulation of tau and glutamatergic cortical neuronal death by unknown mechanisms. We …

Mechanisms of secretion and spreading of pathological tau protein

CA Brunello, M Merezhko, RL Uronen… - Cellular and Molecular …, 2020 - Springer
Accumulation of misfolded and aggregated forms of tau protein in the brain is a
neuropathological hallmark of tauopathies, such as Alzheimer's disease and frontotemporal …

Molecular pathogenesis of the tauopathies

J Götz, G Halliday, RM Nisbet - Annual Review of Pathology …, 2019 - annualreviews.org
The tauopathies constitute a group of diseases that have Tau inclusions in neurons or glia
as their common denominator. In this review, we describe the biochemical and histological …

A walk through tau therapeutic strategies

S Jadhav, J Avila, M Schöll, GG Kovacs… - Acta neuropathologica …, 2019 - Springer
Tau neuronal and glial pathologies drive the clinical presentation of Alzheimer's disease
and related human tauopathies. There is a growing body of evidence indicating that …

Tau as a biomarker of neurodegeneration

S Holper, R Watson, N Yassi - International Journal of Molecular Sciences, 2022 - mdpi.com
Less than 50 years since tau was first isolated from a porcine brain, its detection in femtolitre
concentrations in biological fluids is revolutionizing the diagnosis of neurodegenerative …

Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation

G Calabrese, C Molzahn, T Mayor - Journal of Biological Chemistry, 2022 - ASBMB
The accumulation of protein inclusions is linked to many neurodegenerative diseases that
typically develop in older individuals, due to a combination of genetic and environmental …

Molecular pathology of neurodegenerative diseases: principles and practice

GG Kovacs - Journal of clinical pathology, 2019 - jcp.bmj.com
Neurodegenerative diseases are characterised by selective dysfunction and progressive
loss of synapses and neurons associated with pathologically altered proteins that deposit …